Skip to content

Clinical trials

Cardiomyopathies trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Israel Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20141
20151
20161
20181
20192
20201
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals2
Carmel Medical Center1
Celladon Corporation1
Eidos Therapeutics, a BridgeBio company1
Gilead Sciences1
HaEmek Medical Center, Israel1
Intellia Therapeutics1
Ionis Pharmaceuticals, Inc.1
Rocket Pharmaceuticals Inc.1
Semmelweis University Heart and Vascular Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies12
Amyloidosis5
Amyloidosis, Familial2
Heart Diseases2
Heart Failure2
Alzheimer Disease1
Amyloid Neuropathies, Familial1
Angina Pectoris1
Arrhythmias, Cardiac1
Cardiac Conduction System Disease1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.